MO
Morepen Laboratories Limited
MOREPENLAB.NS · NSE
₹115.72 +0.38% (+₹0.44)
1M +37.52%
Market Cap ₹63.3B
P/E Ratio 45.04x
Div. Yield -
ROE 11.50%
Bulios Fair Price
₹59.15
48.9% downside
Trenutna cena
₹115.72
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica MOREPENLAB.NS trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
3/9Valuation
18 /100
Expensive EV/EBITDA 27.91x
P/S 3.24x
P/B 5.07x
Growth
52 /100
Stable Rev. growth 5.88%
Book val. growth 25.96%
EPS growth 3.93%
Profitability
33 /100
Weak Net margin 7.20%
Op. margin 7.60%
FCF margin 1.27%
Quality
53 /100
Average ROE 11.50%
ROA N/A
Asset turnover N/A
Debt
99 /100
Low Int. coverage 11.09x
Net debt/EBITDA 0.00x
Debt/Equity 0.00x
Stability
63 /100
Moderate Rev. volatility 14.08%
EPS volatility 103.42%
Profitable years 6
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o MOREPENLAB.NS
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Sushil Suri
Employees
2,152
Headquarters
Gurugram
Prihajajoči dogodki
18 SEP.
Ex-Dividend
Ex-dividend date
26 OKT.
Dividend Payment
Datum plačila